These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5004832)

  • 21. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
    Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ
    Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668
    [No Abstract]   [Full Text] [Related]  

  • 22. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract]   [Full Text] [Related]  

  • 23. Rifampicin in the treatment of chronic and polyresistant tuberculosis.
    de Macedo AV
    Respiration; 1971; 28():Suppl:84-90. PubMed ID: 5150798
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 25. A trial of intermittent rifampicin and ethambutol in retreatment regimens.
    Zierski M
    Scand J Respir Dis Suppl; 1973; 84():132-5. PubMed ID: 4522067
    [No Abstract]   [Full Text] [Related]  

  • 26. Rifampin.
    Schonell M; Dorken E; Grzybowski S
    Can Med Assoc J; 1972 Apr; 106(7):783-6. PubMed ID: 4622757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of 200 cases of active, recent pulmonary tuberculosis treated with rifampin-isoniazid. A follow-up history of one and one-half to three years.
    Constans P; Baron A; Parrot R; Coury C
    Chest; 1972 Jun; 61(6):539-49. PubMed ID: 4624276
    [No Abstract]   [Full Text] [Related]  

  • 28. The Australian rifampicin trial.
    Proust A; Evans C
    Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286
    [No Abstract]   [Full Text] [Related]  

  • 29. [Causes of failure in neutralization, recovery and social rehabilitation of chronic eliminators of Koch bacilli treated with rifampin and ethambutol].
    Barbu Z; Alexa M; Josefovics F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):153-9. PubMed ID: 212812
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of daily followed by twice- or once-weekly regimens of ethambutol and rifampicin in the retreatment of patients with pulmonary tuberculosis: second report.
    Tubercle; 1976 Jun; 57(2):105-13. PubMed ID: 822547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium tuberculosis resistance to rifampicin and ethambutol: a clinical survey.
    Macdonald JB
    Thorax; 1977 Feb; 32(1):1-4. PubMed ID: 402706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
    Somner AR; Selkon JB; Walton M; White AB
    Tubercle; 1971 Dec; 52(4):266-75. PubMed ID: 5143922
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical results of rifampicin treatment.
    Virchow C; Flemming J
    Antibiot Chemother; 1970; 16():471-9. PubMed ID: 4108896
    [No Abstract]   [Full Text] [Related]  

  • 34. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
    [No Abstract]   [Full Text] [Related]  

  • 35. Results and tolerance of prolonged rifampicin treatment in recent and chronic forms of pulmonary tuberculosis.
    Nitti V
    Respiration; 1971; 28():Suppl:57-69. PubMed ID: 4948629
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1971 Sep; 46(9):371-7. PubMed ID: 4330662
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs.
    Nitti V
    Antibiot Chemother; 1970; 16():444-70. PubMed ID: 5002308
    [No Abstract]   [Full Text] [Related]  

  • 38. A national therapy project for drug resistant pulmonary tuberculosis.
    Øvreberg K; Bjartveit K
    Scand J Respir Dis; 1974; 55(4):218-28. PubMed ID: 4140569
    [No Abstract]   [Full Text] [Related]  

  • 39. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B; Pretet S
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland.
    Tubercle; 1975 Mar; 56(1):1-26. PubMed ID: 1096388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.